sprite-preloader
Anzeige
Mehr »
Sonntag, 21.07.2019 Börsentäglich über 12.000 News von 616 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

WKN: A0DJ09 ISIN: US74112E1091 Ticker-Symbol: N/A 
Aktie:

Aktuelle News zu PRESSURE BIOSCIENCES Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
DoPressure BioSciences, Inc.: Pressure BioSciences' PCT Platform Highlighted at International Conference in China4
Scientists from the Elite Westlake University Report on the Use of the PCT Platform to Significantly Improve the Preparation of Clinical Laboratory Specimens for Evaluation SOUTH EASTON, MA / ACCESSWIRE...
► Artikel lesen
27.06.Pressure BioSciences launches BaroShear K45 system to manufacture water-soluble CBD-

► Artikel lesen
27.06.Pressure BioSciences, Inc.: Pressure BioSciences Enters CBD Market with Launch of Novel Instrument System to Revolutionize Manufacturing of High Quality, Water-Soluble CBD48
Purchase Deposits for the New BaroShear K45 System Will be Accepted Immediately; Company Believes Sales into the CBD Market Could Double Current Revenue by Q2 2020 SOUTH EASTON, MA / ACCESSWIRE / June...
► Artikel lesen
26.06.Pressure BioSciences pulls off milestone, advances processing method for keeping food and drinks shelf-stable1

► Artikel lesen
26.06.Pressure BioSciences, Inc.: Pressure BioSciences Announces Achievement of First Major Milestone in Development of Potential Breakthrough Processing Method for Higher Quality and Safer Food and Beverages4
Proprietary, Custom Built UST-Based Instrument Delivered to Collaborators at The Ohio State University; OSU Scientists to Study Pressure and Shear Effects on Pathogen Inactivation, Stability, and Quality SOUTH...
► Artikel lesen
19.06.Pressure BioSciences ultra high-pressure HUB platform shines in food safety studies-

► Artikel lesen
19.06.Pressure BioSciences, Inc.: Pressure BioSciences' Ultra High Pressure HUB Platform Highly Effective in Studies to Develop Improved Methods for Food Safety15
HUB Platform Plays Critical Role in Innovative Research Studies Designed to Increase Understanding of and Develop Methods for the Prevention of Serious Food-Borne Diseases Caused by E. coli and Listeria SOUTH...
► Artikel lesen
12.06.Spotlight on Pressure BioSciences' PCT platform at major international science summit1

► Artikel lesen
12.06.Pressure BioSciences, Inc.: Pressure BioSciences' PCT Platform Prominently Featured in Record Number of Presentations at Major International Science Conference6
Scientists from Leading Laboratories in Europe, Asia, Oceania, and North America Highlight the Critical Importance of PBI's Patented PCT System in Cancer and Other Priority Research Areas SOUTH EASTON...
► Artikel lesen
17.05.Pressure BioSciences, Inc. (PBIO) CEO Richard Schumacher on Q1 2019 Results - Earnings Call Transcript-

► Artikel lesen
16.05.Pressure BioSciences 1Q revenue boosted by new BioPharma contract services, Ultra Shear Technology platform-

► Artikel lesen
16.05.Pressure BioSciences reports Q1 results-

► Artikel lesen
16.05.Pressure BioSciences, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update1
Q1 Revenue from Newly Created BioPharma and UST Contract Services Significantly Exceeds Services Revenue for All Quarters of 2018 Combined Investor Conference Call Scheduled for Thursday, May 16, 2019...
► Artikel lesen
16.05.Pressure BioSciences, Inc. to Discuss First Quarter 2019 Financial Results and Provide Business Update4
Conference Call Scheduled for Thursday, May 16th at 4:30pm ET SOUTH EASTON, MA / ACCESSWIRE / May 15, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the...
► Artikel lesen
01.05.PRESSURE BIOSCIENCES INC - 8-K, Current Report-

► Artikel lesen
01.05.Pressure BioSciences CEO Richard Schumacher to step down in September, company outlines succession plan-

► Artikel lesen
01.05.Pressure BioSciences, Inc.: Pressure BioSciences Announces CEO Succession Plan7
Richard T. Schumacher to Step Down as President & CEO on September 9, 2019; Will Remain as Senior Consultant to Support Leadership Transition SOUTH EASTON, MA / ACCESSWIRE / May 1, 2019 / Pressure BioSciences...
► Artikel lesen
25.04.Pressure BioSciences 4Q revenue surges from new biopharma services, UST Shear Technology1

► Artikel lesen
25.04.Pressure BioSciences reports Q4 results-

► Artikel lesen
25.04.Pressure BioSciences, Inc. Reports Record Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update6
Q4 2018 Total Revenue Increases 37% over Q4 2017, Setting New Record Quarterly High; FY 2018 Total Revenue Increases 10% over FY 2017, Setting New Record Annual High; Initial Revenue...
► Artikel lesen
Seite:  Weiter >>
52 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
PRESSURE BIOSCIENCES INC-Investoren interessieren sich auch für diese News

Unternehmen / AktienAktienkurs%Top-Nachrichten
RELAY MEDICAL0,1250,00 %IRW-News: Relay Medical Corp.: Relay Medical erhält von Fio Corporation Lizenz für medizinische Cloud-Software
IRW-PRESS: Relay Medical Corp.: Relay Medical erhält von Fio Corporation Lizenz für medizinische Cloud-Software 2. Juli 2019 - Relay Medical Corp. (Relay oder das Unternehmen) (CSE: RELA, OTC:...
► Artikel lesen
TRISTAR WELLNESS SOLUTIONS--TRISTAR WELLNESS SOLUTIONS, INC. - 15-12G/A, Securities registration termination

► Artikel lesen
CYTOSORBENTS6,67+5,62 %Cytosorbents Corp - 8-K, Current Report

► Artikel lesen
FRESENIUS45,03-0,65 %FMC und Fresenius: Darum stehen sie heute am DAX-Ende
Der deutsche Aktienmarkt kommt nicht auf die Beine. "Es will für den Dax derzeit einfach keine Kaufstimmung aufkommen", erklärte Börsenexperte Andreas Lipkow von der Comdirect Bank am Mittwoch. Insbesondere...
► Artikel lesen
FRESENIUS MEDICAL CARE67,00-1,09 %Noch hinter Wirecard: Fresenius und Fresenius Medical Care am DAX-Ende: Angst vor Trump
Zuletzt konnten die Papiere von Fresenius und der Tochter Fresenius Medical Care (FMC) noch zulegen, am heutigen Mittwoch geht es bei den Aktien jedoch steil bergab. Fresenius Medical Care verliert...
► Artikel lesen
Lade...
FN Beta